Get startedLog in
    Picture of Sangamo Therapeutics logo

    SGMOQ — Sangamo Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Sangamo Therapeutics Q4 EPS USD -0.11 Vs. IBES Estimate USD -0.09

    Picture of Sangamo Therapeutics logoSangamo Therapeutics
    17/03/2025 20:01
    Mar 17 (Reuters) - Sangamo Therapeutics Q4 adjusted operating expenses USD 29 million.

Q4 net income USD -23.396 million

Q4 revenue USD 7.551 million vs. IBES estimate USD 13.6 million

Q4 operating income USD -25.99 million

Q4 operating expenses USD 33.5 million

    Recent news on Sangamo Therapeutics

    See all news